solid

Olympic Agenda lays solid longterm financial base for IOC with revenues up by 60 per cent during the period of implementation

19 March 2025 – The reforms of Olympic Agenda have created a solid long-term financial base for the International Olympic Committee (IOC),…

2 weeks ago
Solid Innovation For Green Tomorrow: XCMG to Launch New Energy Series and Lineup Over 40 Flagship Products at bauma 2025Solid Innovation For Green Tomorrow: XCMG to Launch New Energy Series and Lineup Over 40 Flagship Products at bauma 2025

Solid Innovation For Green Tomorrow: XCMG to Launch New Energy Series and Lineup Over 40 Flagship Products at bauma 2025

MUNICH, March 17, 2025 /PRNewswire/ -- XCMG Machinery  ("XCMG", SHE:000425) is set to exhibit a lineup of over 40 construction equipment…

2 weeks ago
Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI ReportsGlobal Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports

Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports

MILPITAS, Calif., Feb. 18, 2025 /PRNewswire/ -- The global semiconductor manufacturing industry closed 2024 with strong fourth quarter results and solid…

1 month ago
Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic MedicinesSolid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

January 15, 2025 16:05 ET  | Source: Solid Biosciences Inc. - Duchenne: Dosed four patients in INSPIRE DUCHENNE clinical trial;…

3 months ago
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual MeetingFate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting

Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting

Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort…

5 months ago
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual MeetingCellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) --  Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology…

5 months ago